Literature DB >> 17332541

Management of breast cancer in women with BRCA gene mutation.

Malcolm R Kell, John P Burke.   

Abstract

Entities:  

Mesh：

Year:  2007        PMID： 17332541      PMCID： PMC1808129          DOI： 10.1136/bmj.39114.354248.80

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  12 in total

1.  Ten-year multi-institutional results of breast-conserving surgery and radiotherapy in BRCA1/2-associated stage I/II breast cancer.

Authors:  Lori J Pierce; Albert M Levin; Timothy R Rebbeck; Merav A Ben-David; Eitan Friedman; Lawrence J Solin; Eleanor E Harris; David K Gaffney; Bruce G Haffty; Laura A Dawson; Steven A Narod; Ivo A Olivotto; Andrea Eisen; Timothy J Whelan; Olufunmilayo I Olopade; Claudine Isaacs; Sofia D Merajver; Julia S Wong; Judy E Garber; Barbara L Weber
Journal:  J Clin Oncol       Date:  2006-04-24       Impact factor: 44.544

Review 2.  Breast and ovarian cancer.

Authors:  Richard Wooster; Barbara L Weber
Journal:  N Engl J Med       Date:  2003-06-05       Impact factor: 91.245

3.  Population-based study of the relationship of treatment and sociodemographics on quality of life for early stage breast cancer.

Authors:  Nancy K Janz; Mahasin Mujahid; Paula M Lantz; Angela Fagerlin; Barbara Salem; Monica Morrow; Dennis Deapen; Steven J Katz
Journal:  Qual Life Res       Date:  2005-08       Impact factor: 4.147

4.  Effect of short-term hormone replacement therapy on breast cancer risk reduction after bilateral prophylactic oophorectomy in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group.

Authors:  Timothy R Rebbeck; Tara Friebel; Theresa Wagner; Henry T Lynch; Judy E Garber; Mary B Daly; Claudine Isaacs; Olufunmilayo I Olopade; Susan L Neuhausen; Laura van 't Veer; Rosalind Eeles; D Gareth Evans; Gail Tomlinson; Ellen Matloff; Steven A Narod; Andrea Eisen; Susan Domchek; Katrina Armstrong; Barbara L Weber
Journal:  J Clin Oncol       Date:  2005-10-11       Impact factor: 44.544

5.  BRCA1--lots of mutations, lots of dilemmas.

Authors:  F S Collins
Journal:  N Engl J Med       Date:  1996-01-18       Impact factor: 91.245

6.  Outcome of conservatively managed early-onset breast cancer by BRCA1/2 status.

Authors:  Bruce G Haffty; Elizabeth Harrold; Atif J Khan; Pradip Pathare; Tanya E Smith; Bruce C Turner; Peter M Glazer; Barbara Ward; Daryl Carter; Ellen Matloff; Allen E Bale; Mayra Alvarez-Franco
Journal:  Lancet       Date:  2002-04-27       Impact factor: 79.321

7.  Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study. Hereditary Breast Cancer Clinical Study Group.

Authors:  S A Narod; J S Brunet; P Ghadirian; M Robson; K Heimdal; S L Neuhausen; D Stoppa-Lyonnet; C Lerman; B Pasini; P de los Rios; B Weber; H Lynch
Journal:  Lancet       Date:  2000-12-02       Impact factor: 79.321

8.  Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation.

Authors:  Noah D Kauff; Jaya M Satagopan; Mark E Robson; Lauren Scheuer; Martee Hensley; Clifford A Hudis; Nathan A Ellis; Jeff Boyd; Patrick I Borgen; Richard R Barakat; Larry Norton; Mercedes Castiel; Khedoudja Nafa; Kenneth Offit
Journal:  N Engl J Med       Date:  2002-05-20       Impact factor: 91.245

9.  Efficacy of bilateral prophylactic mastectomy in women with a family history of breast cancer.

Authors:  L C Hartmann; D J Schaid; J E Woods; T P Crotty; J L Myers; P G Arnold; P M Petty; T A Sellers; J L Johnson; S K McDonnell; M H Frost; R B Jenkins
Journal:  N Engl J Med       Date:  1999-01-14       Impact factor: 91.245

10.  Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer.

Authors:  Bernard Fisher; Stewart Anderson; John Bryant; Richard G Margolese; Melvin Deutsch; Edwin R Fisher; Jong-Hyeon Jeong; Norman Wolmark
Journal:  N Engl J Med       Date:  2002-10-17       Impact factor: 91.245
View more
  1 in total

Review 1.  Milestones of Precision Medicine: An Innovative, Multidisciplinary Overview.

Authors:  Jesús García-Foncillas; Jesús Argente; Luis Bujanda; Victoria Cardona; Bonaventura Casanova; Ana Fernández-Montes; José A Horcajadas; Andrés Iñiguez; Alberto Ortiz; José L Pablos; María Vanessa Pérez Gómez
Journal:  Mol Diagn Ther       Date:  2021-07-30       Impact factor: 4.074
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.